Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

177 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
BAVC regimen in CR AML patients.
Meloni G, Vignetti M, De Fabritiis P, Petti MC, Pinto MR, Testi AM, Vegna ML, Mandelli F. Meloni G, et al. Among authors: petti mc. Bone Marrow Transplant. 1991;7 Suppl 2:134. Bone Marrow Transplant. 1991. PMID: 1878679 Clinical Trial. No abstract available.
Therapy of acute myelogenous leukemia in adults.
Petti MC, Broccia G, Caronia F, Di Raimondo F, Fioritoni G, Ladogana S, Leone G, Liso V, Musso M, Neri A, et al. Petti MC, et al. Haematol Blood Transfus. 1990;33:249-53. doi: 10.1007/978-3-642-74643-7_45. Haematol Blood Transfus. 1990. PMID: 2182417 Clinical Trial. No abstract available.
Idarubicin in acute leukaemia. GIMEMA Group.
Mandelli F, Annino L, Avvisati G, Giona F, Meloni G, Petti MC, Testi AM, Carella AM, Caronia F, Carotenuto M, et al. Mandelli F, et al. Among authors: petti mc. Bone Marrow Transplant. 1989 Dec;4 Suppl 3:49-52. Bone Marrow Transplant. 1989. PMID: 2697401 Clinical Trial. No abstract available.
Prognostic factors of patients with acute myeloid leukemia (AML) allografted in first complete remission: an analysis of the EORTC-GIMEMA AML 8A trial. The European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell' Adulto (GIMEMA) Leukemia Cooperative Groups.
Keating S, Suciu S, de Witte T, Mandelli F, Willemze R, Resegotti L, Broccia G, Thaler J, Labar B, Damasio E, Bizzi B, Rotoli B, Vekhoff A, Muus P, Petti MC, Dardenne M, Solbu G, Vegna ML, Zittoun RA. Keating S, et al. Among authors: petti mc. Bone Marrow Transplant. 1996 Jun;17(6):993-1001. Bone Marrow Transplant. 1996. PMID: 8807105 Clinical Trial.
A randomised clinical trial comparing idarubicin and cytarabine to daunorubicin and cytarabine in the treatment of acute non-lymphoid leukaemia. A multicentric study from the Italian Co-operative Group GIMEMA.
Mandelli F, Petti MC, Ardia A, Di Pietro N, Di Raimondo F, Ganzina F, Falconi E, Geraci E, Ladogana S, Latagliata R, et al. Mandelli F, et al. Among authors: petti mc. Eur J Cancer. 1991;27(6):750-5. doi: 10.1016/0277-5379(91)90181-c. Eur J Cancer. 1991. PMID: 1829918 Clinical Trial.
Idarubicin (4-demethoxydaunorubicin) as single agent for remission induction of previously untreated acute promyelocytic leukemia: a pilot study of the Italian cooperative group GIMEMA.
Avvisati G, Mandelli F, Petti MC, Vegna ML, Spadea A, Liso V, Specchia G, Bernasconi C, Alessandrino EP, Piatti C, et al. Avvisati G, et al. Among authors: petti mc. Eur J Haematol. 1990 Apr;44(4):257-60. doi: 10.1111/j.1600-0609.1990.tb00389.x. Eur J Haematol. 1990. PMID: 2188854 Clinical Trial.
177 results